Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Wong

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
The American Journal of Gastroenterology|March 8, 2024
Correction to: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 8, 2024
2024 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong Kong, Tai-Pang Ip, Chun-Hong Alan Lee, et al.
Hepatology International|January 25, 2022
Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapyGeorge Lau, Ming-Lung Yu, Grace Wong, et al.
Hepatology International|August 24, 2021
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapyGeorge Lau, Ming-Lung Yu, Grace Wong, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
Hepatology International|December 5, 2020
HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohortYasuhito Tanaka, Eiichi Ogawa, Chung-Feng Huang, et al.
Hepatology International|August 30, 2019
Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C ConsortiumChung-Feng Huang, Etsuko Iio, Dae Won Jun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 29, 2019
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice ImplicationEiichi Ogawa, Hidenori Toyoda, Etsuko Iio, et al.
Hepatology International|June 5, 2023
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C studyYu Jun Wong, Sally Tran, Chung-Feng Huang, et al.
Journal of Clinical and Translational Hepatology|July 12, 2024
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort StudyFanpu Ji, Sally Tran, Eiichi Ogawa, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
The American Journal of Gastroenterology|March 8, 2024
Correction to: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 8, 2024
2024 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong Kong, Tai-Pang Ip, Chun-Hong Alan Lee, et al.
Hepatology International|January 25, 2022
Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapyGeorge Lau, Ming-Lung Yu, Grace Wong, et al.
Hepatology International|August 24, 2021
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapyGeorge Lau, Ming-Lung Yu, Grace Wong, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
Hepatology International|December 5, 2020
HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohortYasuhito Tanaka, Eiichi Ogawa, Chung-Feng Huang, et al.
Hepatology International|August 30, 2019
Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C ConsortiumChung-Feng Huang, Etsuko Iio, Dae Won Jun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 29, 2019
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice ImplicationEiichi Ogawa, Hidenori Toyoda, Etsuko Iio, et al.
Hepatology International|June 5, 2023
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C studyYu Jun Wong, Sally Tran, Chung-Feng Huang, et al.
Journal of Clinical and Translational Hepatology|July 12, 2024
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort StudyFanpu Ji, Sally Tran, Eiichi Ogawa, et al.
Pageof 10